Abstract:Poly(ADP-ribosyl) ation is a reversible post-translational protein modification implicated in the regulation of a number of biological functions. Whereas an 18 member superfamily of poly(ADP-ribose) polymerase (PARP) enzymes synthesize poly(ADP-ribose) (PAR), a single protein, PAR glycohydrolase (PARG) is responsible for the catabolism of the polymer. PARP-1 accounts for more than 90% of the poly(ADP-ribosyl)ating capacity of the cells. PARP-1 activated by DNA breaks cleaves NAD(+) into nicotinamide and ADP-ribose and uses the latter to synthesize long branching PAR polymers covalently attached to acceptor proteins including histones, DNA repair enzymes, transcription factors and PARP-1. Whereas activation of PARP-1 by mild genotoxic stimuli may facilitate DNA repair and cell survival, irreparable DNA damage triggers apoptotic or necrotic cell death. In apoptosis, early PARP activation may assist the apoptotic cascade [e.g. by stabilizing p53, by mediating the translocation of apoptosis inducing factor (AIF) from the mitochondria to the nucleus or by inhibiting early activation of DNases]. In most severe oxidative stress situations, excessive DNA damage causes over activation of PARP-1, which incapacitates the apoptotic machinery and switches the mode of cell death from apoptosis to necrosis. Besides serving as a cytotoxic mediator, PARP-1 is also involved in transcriptional regulation, most notably in the NF kappaB and AP-1 driven expression of inflammatory mediators. Pharmacological inhibition or genetic ablation of PARP-1 provided remarkable protection from tissue injury in various oxidative stress-related disease models ranging from stroke, diabetes, diabetic endothelial dysfunction, myocardial ischemia-reperfusion, shock, Parkinson's disease, arthritis, colitis to dermatitis and uveitis. These beneficial effects are attributed to inhibition of the PARP-1 mediated suicidal pathway and to reduced expression of inflammatory cytokines and other mediators (e.g. inducible nitric oxide synthase).

Poly (Adp-Ribose) Polymerase-1 and Ischemic Brain Injury

The role of PARP-1 on brain ischemia injury and brain-protection therapy

[Poly Adenosine Diphosphate-Ribosylation and Neurodegenerative Diseases].

PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

PARP Inhibition Attenuates Early Brain Injury Through NF-κB/MMP-9 Pathway in a Rat Model of Subarachnoid Hemorrhage.

[Roles of Protease-Activated Receptor-1 in Thrombin-Induced Brain Injury and Neurogenesis in Rats].

ADP-ribose Transferase PARP16 Mediated-Unfolded Protein Response Contributes to Neuronal Cell Damage in Cerebral Ischemia/reperfusion

The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future

Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo

PARP-1 dependent cell death pathway (Parthanatos) mediates early brain injury after subarachnoid hemorrhage

Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: from Molecular Mechanisms to Therapeutic Implications

PARP1 Promotes Heart Regeneration and Cardiomyocyte Proliferation

Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies

PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities

Investigation of the mechanism of poly (ADP-ribose) polymerase (PARP) in elderly mouse myocardial ischemia-reperfusion injury

Role of Pericyte‐derived SENP1 in Neuronal Injury after Brain Ischemia

A Dual Role for Poly‐adp‐ribosylation in Spatial Memory Acquisition after Traumatic Brain Injury in Mice Involving NAD+ Depletion and Ribosylation of 14‐3‐3Γ

Resveratrol Preconditioning Downregulates PARP1 Protein to Alleviate PARP1-Mediated Cell Death Following Cerebral Ischemia

Role of protease activated receptor-1 in thrombin preconditioning against thrombin-induced brain injury in mice